IRIS
BRUNETTI, Lorenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.003
EU - Europa 898
AS - Asia 184
AF - Africa 6
Totale 2.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.002
RU - Federazione Russa 604
IE - Irlanda 105
SG - Singapore 79
SE - Svezia 76
CN - Cina 63
IT - Italia 49
IN - India 32
GB - Regno Unito 30
FR - Francia 10
BE - Belgio 8
CI - Costa d'Avorio 6
DE - Germania 6
FI - Finlandia 6
KR - Corea 4
PK - Pakistan 4
AT - Austria 1
CA - Canada 1
GR - Grecia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
RO - Romania 1
Totale 2.091
Salva come PNG Salva come JPEG
Città #
Chandler 338
Dublin 99
Boardman 80
Ashburn 78
Fairfield 48
Lawrence 35
Princeton 35
Pune 32
Singapore 31
Wilmington 30
Ancona 20
Cambridge 16
London 16
Los Angeles 16
Des Moines 14
Bologna 10
Shanghai 10
Washington 10
Woodbridge 10
San Diego 9
Brussels 8
Dallas 8
Haikou 8
Houston 7
Seattle 7
Abidjan 6
Helsinki 6
New York 6
Beijing 5
Guangzhou 5
Ann Arbor 4
Jiaxing 4
Acton 3
Prescot 3
Wuhan 3
Buffalo 2
Hounslow 2
Kilburn 2
Nuremberg 2
Rome 2
Sacramento 2
Santa Clara 2
Seoul 2
Shenzhen 2
Verona 2
Yuseong-gu 2
Atlanta 1
Changsha 1
Dalian 1
Heze 1
Islington 1
Jinhua 1
Longyan 1
Norwalk 1
Perugia 1
Redmond 1
San Francisco 1
San Mateo 1
Sesto Fiorentino 1
Southwark 1
Taizhou 1
Tel Aviv 1
Thessaloniki 1
Vientiane 1
Vilnius 1
Wandsworth 1
Wuxi 1
Yiwu 1
Totale 1.064
Salva come PNG Salva come JPEG
Nome #
Highly efficient gene disruption of murine and human hematopoietic progenitor cells by CRISPR/Cas9 637
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 90
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics 61
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 52
How I diagnose and treat NPM1-mutated AML 50
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression 49
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9 48
NPM1-mutated acute myeloid leukemia: From bench to bedside 47
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy 44
CD123 is consistently expressed on NPM1-mutated AML cells 43
DNMT3A in Leukemia 41
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 40
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 39
Aerobic Plus Resistance Exercise in Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Weight Loss 38
Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field 37
CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells: Correspondence 36
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 36
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice 35
Nutrient-sensitive transcription factors TFEB and TFE3 couple autophagy and metabolism to the peripheral clock 35
Response to: “Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” 34
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1 33
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 32
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome 32
Dactinomycin in NPM1-Mutated acute myeloid leukemia 31
Effect of the COVID-19 pandemic on laboratory and clinical research: A testimony and a call to action from researchers 31
TFEB regulates murine liver cell fate during development and regeneration 30
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells 29
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 29
Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma 29
AML-099 Prolonged XPO1 Inhibition Is Essential for Optimal Anti-Leukemic Activity in NPM1-Mutated AML 28
Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor 28
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: A shared clonal origin 27
null 27
NOVEL NPM1 EXON 5 MUTATIONS AND GENE FUSIONS LEADING TO ABERRANT CYTOPLASMIC NUCLEOPHOSMIN IN AML 27
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities 26
Current status and future perspectives in targeted therapy of NPM1-mutated AML 25
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion 24
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells 24
New insights into the biology of acute myeloid leukemia with mutated NPM1 23
Mutant NPM1 Maintains the Leukemic State through HOX Expression 21
Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia 20
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 20
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis 15
NPM1-mutated AML with starry sky pattern 14
Overlapping features of therapy-related and de novoNPM1-mutated AML 12
Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells 9
An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant 8
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A 6
Breast Cancer With Release of Tumor Cells in Peripheral Blood Mimicking Acute Myeloid Leukemia 6
The NPM1 mutant defines AML irrespective of blast count 4
Prolonged XPO1 inhibition is essential for optimal anti-leukemic activity in NPM1-mutated AML 2
Totale 2.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.973
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 3 0
2021/2022288 0 18 0 0 53 48 1 11 49 8 22 78
2022/2023689 67 80 49 77 49 64 6 57 171 2 29 38
2023/2024970 80 15 37 50 48 205 130 132 77 98 56 42
2024/2025214 77 76 13 18 19 11 0 0 0 0 0 0
Totale 2.164